Cargando…

A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course

Detalles Bibliográficos
Autores principales: Hartikainen, J, Kataja, V, Mannermaa, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300896/
http://dx.doi.org/10.1186/bcr95
_version_ 1782226384058318848
author Hartikainen, J
Kataja, V
Mannermaa, A
author_facet Hartikainen, J
Kataja, V
Mannermaa, A
author_sort Hartikainen, J
collection PubMed
description
format Online
Article
Text
id pubmed-3300896
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33008962012-03-14 A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course Hartikainen, J Kataja, V Mannermaa, A Breast Cancer Res Meeting Abstract BioMed Central 2000 2000-03-12 /pmc/articles/PMC3300896/ http://dx.doi.org/10.1186/bcr95 Text en Copyright ©2000 Current Science Ltd
spellingShingle Meeting Abstract
Hartikainen, J
Kataja, V
Mannermaa, A
A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_full A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_fullStr A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_full_unstemmed A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_short A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_sort novel brca2 gene mutation, 4081 insa, in a finnish breast/ovarian cancer family associated with favourable clinical course
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300896/
http://dx.doi.org/10.1186/bcr95
work_keys_str_mv AT hartikainenj anovelbrca2genemutation4081insainafinnishbreastovariancancerfamilyassociatedwithfavourableclinicalcourse
AT katajav anovelbrca2genemutation4081insainafinnishbreastovariancancerfamilyassociatedwithfavourableclinicalcourse
AT mannermaaa anovelbrca2genemutation4081insainafinnishbreastovariancancerfamilyassociatedwithfavourableclinicalcourse
AT hartikainenj novelbrca2genemutation4081insainafinnishbreastovariancancerfamilyassociatedwithfavourableclinicalcourse
AT katajav novelbrca2genemutation4081insainafinnishbreastovariancancerfamilyassociatedwithfavourableclinicalcourse
AT mannermaaa novelbrca2genemutation4081insainafinnishbreastovariancancerfamilyassociatedwithfavourableclinicalcourse